Hong Kong · Delayed Price · Currency is HKD Qyuns Therapeutics Statistics
Total Valuation
HKG:2509 has a market cap or net worth of HKD 3.67 billion. The enterprise value is 3.14 billion.
| Market Cap | 3.67B |
| Enterprise Value | 3.14B |
Important Dates
The last earnings date was Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2509 has 224.57 million shares outstanding. The number of shares has increased by 1.94% in one year.
| Current Share Class | 224.57M |
| Shares Outstanding | 224.57M |
| Shares Change (YoY) | +1.94% |
| Shares Change (QoQ) | +1.46% |
| Owned by Insiders (%) | 4.45% |
| Owned by Institutions (%) | 14.14% |
| Float | 106.78M |
Valuation Ratios
The trailing PE ratio is 10.44 and the forward PE ratio is 16.30.
| PE Ratio | 10.44 |
| Forward PE | 16.30 |
| PS Ratio | 4.08 |
| PB Ratio | 4.85 |
| P/TBV Ratio | 4.77 |
| P/FCF Ratio | 8.40 |
| P/OCF Ratio | 8.24 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.78, with an EV/FCF ratio of 7.18.
| EV / Earnings | 8.96 |
| EV / Sales | 3.49 |
| EV / EBITDA | 7.78 |
| EV / EBIT | 8.54 |
| EV / FCF | 7.18 |
Financial Position
The company has a current ratio of 2.22, with a Debt / Equity ratio of 0.85.
| Current Ratio | 2.22 |
| Quick Ratio | 2.11 |
| Debt / Equity | 0.85 |
| Debt / EBITDA | 1.60 |
| Debt / FCF | 1.48 |
| Interest Coverage | 17.17 |
Financial Efficiency
Return on equity (ROE) is 68.31% and return on invested capital (ROIC) is 20.55%.
| Return on Equity (ROE) | 68.31% |
| Return on Assets (ROA) | 15.97% |
| Return on Invested Capital (ROIC) | 20.55% |
| Return on Capital Employed (ROCE) | 30.11% |
| Weighted Average Cost of Capital (WACC) | 10.74% |
| Revenue Per Employee | 2.66M |
| Profits Per Employee | 1.04M |
| Employee Count | 337 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 15.70 |
Taxes
| Income Tax | -81,235 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +45.54% in the last 52 weeks. The beta is 1.44, so HKG:2509's price volatility has been higher than the market average.
| Beta (5Y) | 1.44 |
| 52-Week Price Change | +45.54% |
| 50-Day Moving Average | 18.24 |
| 200-Day Moving Average | 21.85 |
| Relative Strength Index (RSI) | 41.41 |
| Average Volume (20 Days) | 252,130 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2509 had revenue of HKD 897.99 million and earned 349.92 million in profits. Earnings per share was 1.56.
| Revenue | 897.99M |
| Gross Profit | 795.00M |
| Operating Income | 367.37M |
| Pretax Income | 342.05M |
| Net Income | 349.92M |
| EBITDA | 401.32M |
| EBIT | 367.37M |
| Earnings Per Share (EPS) | 1.56 |
Balance Sheet
The company has 1.16 billion in cash and 645.44 million in debt, with a net cash position of 514.79 million or 2.29 per share.
| Cash & Cash Equivalents | 1.16B |
| Total Debt | 645.44M |
| Net Cash | 514.79M |
| Net Cash Per Share | 2.29 |
| Equity (Book Value) | 755.70M |
| Book Value Per Share | 3.42 |
| Working Capital | 682.07M |
Cash Flow
In the last 12 months, operating cash flow was 444.95 million and capital expenditures -8.32 million, giving a free cash flow of 436.63 million.
| Operating Cash Flow | 444.95M |
| Capital Expenditures | -8.32M |
| Depreciation & Amortization | 35.26M |
| Net Borrowing | 59.39M |
| Free Cash Flow | 436.63M |
| FCF Per Share | 1.94 |
Margins
Gross margin is 88.53%, with operating and profit margins of 40.91% and 38.97%.
| Gross Margin | 88.53% |
| Operating Margin | 40.91% |
| Pretax Margin | 38.09% |
| Profit Margin | 38.97% |
| EBITDA Margin | 44.69% |
| EBIT Margin | 40.91% |
| FCF Margin | 48.62% |
Dividends & Yields
HKG:2509 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.94% |
| Shareholder Yield | -1.94% |
| Earnings Yield | 9.54% |
| FCF Yield | 11.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for HKG:2509 is 33.00, which is 100.73% higher than the current price. The consensus rating is "Buy".
| Price Target | 33.00 |
| Price Target Difference | 100.73% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:2509 has an Altman Z-Score of 3.04 and a Piotroski F-Score of 8.
| Altman Z-Score | 3.04 |
| Piotroski F-Score | 8 |